Literature DB >> 6799508

Vitamin K-dependent carboxylation. Evidence that at least two microsomal dehydrogenases reduce vitamin K1 to support carboxylation.

R Wallin, S Hutson.   

Abstract

It has been shown that NAD(P)H dehydrogenase (EC 1.6.99.2) reduces vitamin K1 and can support the [vitamin K1 + NADH]-dependent carboxylation reaction in rat liver microsomes (Wallin, R., Gebhardt, O., and Prydz, H. (1978) Biochem. J. 169, 95-101). Antibodies were raised in rabbits against the purified enzyme from liver cytosol and used to study the importance of NAD(P)H dehydrogenase in the vitamin K-dependent carboxylation reaction. The antibodies neutralized the warfarin-sensitive NAD(P)H dehydrogenase activity in Triton X-100-solubilized microsomes; however, they neutralized only 45% of the total [vitamin K1 + NADH]-dependent carboxylation activity. Chromatography on protein A-sepharose showed that the remaining carboxylase activity was not the result of soluble antigen-antibody complexes. The data presented support the conclusion that the microsomal preparation also contains a non-warfarin-sensitive dehydrogenase(s) that, in addition to NAD(P)H dehydrogenase, can reduce vitamin K1 to support the carboxylation reaction.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6799508

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

Review 1.  Gamma-carboxyglutamate-containing proteins and the vitamin K-dependent carboxylase.

Authors:  C Vermeer
Journal:  Biochem J       Date:  1990-03-15       Impact factor: 3.857

2.  Vitamin K1 reduction in human liver. Location of the coumarin-drug-insensitive enzyme.

Authors:  R Wallin; S D Patrick; L F Martin
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

3.  Functional study of the vitamin K cycle in mammalian cells.

Authors:  Jian-Ke Tie; Da-Yun Jin; David L Straight; Darrel W Stafford
Journal:  Blood       Date:  2011-01-14       Impact factor: 22.113

Review 4.  Recent trends in the metabolism and cell biology of vitamin K with special reference to vitamin K cycling and MK-4 biosynthesis.

Authors:  Martin J Shearer; Paul Newman
Journal:  J Lipid Res       Date:  2014-01-31       Impact factor: 5.922

Review 5.  Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations.

Authors:  G Palareti; C Legnani
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

6.  Purification and characterization of two forms of microsomal carbonyl reductase in guinea pig liver.

Authors:  S Usui; A Hara; T Nakayama; H Sawada
Journal:  Biochem J       Date:  1984-11-01       Impact factor: 3.857

7.  Warfarin and vitamin K compete for binding to Phe55 in human VKOR.

Authors:  Katrin J Czogalla; Arijit Biswas; Klara Höning; Veit Hornung; Kerstin Liphardt; Matthias Watzka; Johannes Oldenburg
Journal:  Nat Struct Mol Biol       Date:  2016-12-12       Impact factor: 15.369

Review 8.  Hereditary combined deficiency of the vitamin K-dependent clotting factors.

Authors:  Mariasanta Napolitano; Guglielmo Mariani; Mario Lapecorella
Journal:  Orphanet J Rare Dis       Date:  2010-07-14       Impact factor: 4.123

Review 9.  Coronary arterial calcification as an active process: a new perspective on an old problem.

Authors:  T M Doherty; R C Detrano
Journal:  Calcif Tissue Int       Date:  1994-03       Impact factor: 4.333

10.  Vitamin K-dependent carboxylation and vitamin K metabolism in liver. Effects of warfarin.

Authors:  R Wallin; L F Martin
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.